Skip to main content

Table 3 Incidence of persistent disseminated tumor cells 12 and 24 months after diagnosis

From: Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial

 

ZOL group n (%)

Control group n (%)

Second BM aspiration performed after 12 months

34 (100%)

37 (100%)

DTC detected after 12 months

4 (12%)

10 (27%)

Third BM aspiration performed after 24 months

27 (100%)

32 (100%)

DTC detected after 24 months

0 (0%)

5 (16%)